Obesity and perioperative outcomes in endometrial cancer surgery

Joseph Santoso, Ginny Barton, Shannon Riedley-Malone, Jim Wan

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective Obesity is a significant risk factor in developing endometrial cancer. As obesity is becoming more endemic, we wish to evaluate the impact of obesity on perioperative outcomes in patients undergoing uterine cancer surgery. Methods We analyzed our prospective database on patients with endometrial cancer who underwent abdominal hysterectomy and pelvic/aortic lymphadenectomy by one gynecologic oncologist. Information regarding race, age, body mass index (BMI), lymph node counts, staging, and estimated blood loss were analyzed against patient's weight category. Weight category was divided as follows: Normal weight (BMI\25), overweight (BMI 25 to\30), obese (BMI 30 to\35) and morbid obesity (BMI C 35). Results Between April 2003 and December 2009, 233 patients were recruited prospectively. This study found no difference in the number of lymph nodes harvested patient (P = 0.0539) or length of hospital stay (P = 0.4234) in patients with a normal BMI versus that of an overweight, obese, or morbidly obese. However, estimated blood loss (P = 0.01) and operative time (P = 0.0015) were greater as BMI increased. African American patients were more morbidly obese than Caucasian patients. Furthermore, younger patients tend to be more obese across all races. Finally, obesity did not affect perioperative complications (P = 0.78). Conclusion Obesity increases surgical blood loss and operative time. However, obesity does not affect length of hospital stay, number of lymph nodes harvested, or perioperative complications in uterine cancer staging surgery.

Original languageEnglish (US)
Pages (from-to)1139-1144
Number of pages6
JournalArchives of Gynecology and Obstetrics
Volume285
Issue number4
DOIs
StatePublished - Apr 1 2012

Fingerprint

Endometrial Neoplasms
Obesity
Body Mass Index
Length of Stay
Uterine Neoplasms
Lymph Nodes
Operative Time
Weights and Measures
Surgical Blood Loss
Morbid Obesity
Neoplasm Staging
Lymph Node Excision
Hysterectomy
African Americans
Databases

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Obesity and perioperative outcomes in endometrial cancer surgery. / Santoso, Joseph; Barton, Ginny; Riedley-Malone, Shannon; Wan, Jim.

In: Archives of Gynecology and Obstetrics, Vol. 285, No. 4, 01.04.2012, p. 1139-1144.

Research output: Contribution to journalArticle

Santoso, Joseph ; Barton, Ginny ; Riedley-Malone, Shannon ; Wan, Jim. / Obesity and perioperative outcomes in endometrial cancer surgery. In: Archives of Gynecology and Obstetrics. 2012 ; Vol. 285, No. 4. pp. 1139-1144.
@article{54f0968ba9be4dcfad90a896909f003c,
title = "Obesity and perioperative outcomes in endometrial cancer surgery",
abstract = "Objective Obesity is a significant risk factor in developing endometrial cancer. As obesity is becoming more endemic, we wish to evaluate the impact of obesity on perioperative outcomes in patients undergoing uterine cancer surgery. Methods We analyzed our prospective database on patients with endometrial cancer who underwent abdominal hysterectomy and pelvic/aortic lymphadenectomy by one gynecologic oncologist. Information regarding race, age, body mass index (BMI), lymph node counts, staging, and estimated blood loss were analyzed against patient's weight category. Weight category was divided as follows: Normal weight (BMI\25), overweight (BMI 25 to\30), obese (BMI 30 to\35) and morbid obesity (BMI C 35). Results Between April 2003 and December 2009, 233 patients were recruited prospectively. This study found no difference in the number of lymph nodes harvested patient (P = 0.0539) or length of hospital stay (P = 0.4234) in patients with a normal BMI versus that of an overweight, obese, or morbidly obese. However, estimated blood loss (P = 0.01) and operative time (P = 0.0015) were greater as BMI increased. African American patients were more morbidly obese than Caucasian patients. Furthermore, younger patients tend to be more obese across all races. Finally, obesity did not affect perioperative complications (P = 0.78). Conclusion Obesity increases surgical blood loss and operative time. However, obesity does not affect length of hospital stay, number of lymph nodes harvested, or perioperative complications in uterine cancer staging surgery.",
author = "Joseph Santoso and Ginny Barton and Shannon Riedley-Malone and Jim Wan",
year = "2012",
month = "4",
day = "1",
doi = "10.1007/s00404-011-2116-2",
language = "English (US)",
volume = "285",
pages = "1139--1144",
journal = "Archives of Gynecology and Obstetrics",
issn = "0932-0067",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Obesity and perioperative outcomes in endometrial cancer surgery

AU - Santoso, Joseph

AU - Barton, Ginny

AU - Riedley-Malone, Shannon

AU - Wan, Jim

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Objective Obesity is a significant risk factor in developing endometrial cancer. As obesity is becoming more endemic, we wish to evaluate the impact of obesity on perioperative outcomes in patients undergoing uterine cancer surgery. Methods We analyzed our prospective database on patients with endometrial cancer who underwent abdominal hysterectomy and pelvic/aortic lymphadenectomy by one gynecologic oncologist. Information regarding race, age, body mass index (BMI), lymph node counts, staging, and estimated blood loss were analyzed against patient's weight category. Weight category was divided as follows: Normal weight (BMI\25), overweight (BMI 25 to\30), obese (BMI 30 to\35) and morbid obesity (BMI C 35). Results Between April 2003 and December 2009, 233 patients were recruited prospectively. This study found no difference in the number of lymph nodes harvested patient (P = 0.0539) or length of hospital stay (P = 0.4234) in patients with a normal BMI versus that of an overweight, obese, or morbidly obese. However, estimated blood loss (P = 0.01) and operative time (P = 0.0015) were greater as BMI increased. African American patients were more morbidly obese than Caucasian patients. Furthermore, younger patients tend to be more obese across all races. Finally, obesity did not affect perioperative complications (P = 0.78). Conclusion Obesity increases surgical blood loss and operative time. However, obesity does not affect length of hospital stay, number of lymph nodes harvested, or perioperative complications in uterine cancer staging surgery.

AB - Objective Obesity is a significant risk factor in developing endometrial cancer. As obesity is becoming more endemic, we wish to evaluate the impact of obesity on perioperative outcomes in patients undergoing uterine cancer surgery. Methods We analyzed our prospective database on patients with endometrial cancer who underwent abdominal hysterectomy and pelvic/aortic lymphadenectomy by one gynecologic oncologist. Information regarding race, age, body mass index (BMI), lymph node counts, staging, and estimated blood loss were analyzed against patient's weight category. Weight category was divided as follows: Normal weight (BMI\25), overweight (BMI 25 to\30), obese (BMI 30 to\35) and morbid obesity (BMI C 35). Results Between April 2003 and December 2009, 233 patients were recruited prospectively. This study found no difference in the number of lymph nodes harvested patient (P = 0.0539) or length of hospital stay (P = 0.4234) in patients with a normal BMI versus that of an overweight, obese, or morbidly obese. However, estimated blood loss (P = 0.01) and operative time (P = 0.0015) were greater as BMI increased. African American patients were more morbidly obese than Caucasian patients. Furthermore, younger patients tend to be more obese across all races. Finally, obesity did not affect perioperative complications (P = 0.78). Conclusion Obesity increases surgical blood loss and operative time. However, obesity does not affect length of hospital stay, number of lymph nodes harvested, or perioperative complications in uterine cancer staging surgery.

UR - http://www.scopus.com/inward/record.url?scp=84863207066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863207066&partnerID=8YFLogxK

U2 - 10.1007/s00404-011-2116-2

DO - 10.1007/s00404-011-2116-2

M3 - Article

VL - 285

SP - 1139

EP - 1144

JO - Archives of Gynecology and Obstetrics

JF - Archives of Gynecology and Obstetrics

SN - 0932-0067

IS - 4

ER -